Aspect Biosystems combines 3D bioprinting, therapeutic cells, and computational design to create implantable tissue therapeutics.
The platform aims to deliver a new class of regenerative medicine, beginning with metabolic and endocrine diseases such as diabetes.
Founders
Tamer Mohammed
Co-Founder
Sam Wadsworth
Co-Founder
Simon Beyer
Co-Founder